Ozempic Acid Reflux: Why GLP-1s Cause Heartburn and How to Fix It

Acid reflux — that burning sensation behind the breastbone, the sour taste in the back of the throat, the feeling that stomach contents are creeping upward — has become an increasingly reported side effect among patients taking GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound). Clinical trials reported GERD-related symptoms in approximately 5-10% of semaglutide users, but real-world patient reports suggest the prevalence may be higher, particularly during dose escalation and in patients with pre-existing reflux tendencies. The irony is notable: these medications slow digestion to reduce appetite, but that same slowed digestion can send stomach contents in the wrong direction. This article explains the specific mechanisms by which GLP-1 medications promote acid reflux, evaluates the over-the-counter and prescription options that provide relief, and covers the lifestyle and dietary modifications that make the biggest difference.

Why GLP-1 Medications Cause Acid Reflux

The relationship between GLP-1 receptor agonists and acid reflux involves several converging mechanisms. The most important is delayed gastric emptying. When food remains in the stomach for extended periods — as it does with semaglutide and tirzepatide, which slow gastric emptying by 30-50% — the stomach remains distended for longer. A distended stomach exerts pressure on the lower esophageal sphincter (LES), the muscular valve separating the stomach from the esophagus. When intragastric pressure exceeds LES pressure, gastric contents reflux upward into the esophagus, causing heartburn.

The second mechanism involves the LES directly. GLP-1 receptors are present on smooth muscle throughout the gastrointestinal tract, and some research suggests that GLP-1 receptor activation may reduce LES tone — the baseline pressure that keeps the sphincter closed between swallows. A 2022 study in Neurogastroenterology and Motility demonstrated that GLP-1 receptor agonists affected esophageal motility parameters in a subset of patients, though the clinical significance varies. Even a modest reduction in LES pressure, combined with increased intragastric pressure from delayed emptying, can create a reflux-prone environment.

Third, GLP-1 medications alter gastric acid secretion patterns. While GLP-1 receptor activation has been shown to reduce meal-stimulated acid secretion in some studies, the prolonged retention of food means that whatever acid is produced remains in contact with the gastric contents for much longer. Additionally, the nausea that frequently accompanies GLP-1 treatment may increase episodes of retching or mini-vomiting events that expose the esophagus to acid. Patients often describe a symptom that falls somewhere between severe nausea and actual vomiting — a forceful sensation in the throat that brings up small amounts of acidic stomach contents.

Is It Acid Reflux or GLP-1 Nausea?

Distinguishing between acid reflux and the generalized nausea that accompanies GLP-1 treatment is important because the management strategies differ. Acid reflux typically presents as a burning sensation behind the breastbone (heartburn), a sour or bitter taste in the mouth, the sensation of food or liquid rising in the throat (regurgitation), a persistent cough or throat clearing, and worsening when lying down or bending over. GLP-1 nausea, by contrast, is typically a diffuse queasy feeling in the upper abdomen, does not involve a burning sensation, is worst in the first 30-60 minutes after eating, and is not position-dependent. Many patients experience both simultaneously, which is not surprising given that the underlying mechanism — a full, slowly emptying stomach — drives both symptoms.

Over-the-Counter Options: Antacids, H2 Blockers, and PPIs

Over-the-counter acid-suppressing medications are the first-line approach for managing GLP-1-related reflux, and there are three categories to understand. Antacids like Tums (calcium carbonate), Maalox, and Mylanta provide immediate but short-lived relief by directly neutralizing stomach acid. They work within minutes and last 1-3 hours. They are best used for occasional, predictable reflux — for example, if you know that eating dinner on your injection day triggers heartburn. The limitation is that they do nothing to prevent acid production, so they must be taken reactively.

H2 receptor blockers — famotidine (Pepcid) and cimetidine (Tagamet) — reduce acid production by blocking histamine-2 receptors on acid-producing parietal cells in the stomach. They take 30-60 minutes to start working but last 8-12 hours. Famotidine 20mg taken 30 minutes before a meal is a practical option for GLP-1 patients who experience predictable post-meal reflux. H2 blockers are generally well-tolerated and can be used daily for up to 2 weeks OTC without physician consultation.

Proton pump inhibitors (PPIs) — omeprazole (Prilosec), esomeprazole (Nexium), and lansoprazole (Prevacid) — are the most potent acid suppressors available OTC. They work by irreversibly inhibiting the proton pump on parietal cells, reducing acid production by up to 90%. PPIs take 2-5 days to reach full effect and are designed for daily use over a 14-day course. They are appropriate when reflux is persistent enough to warrant continuous suppression rather than as-needed relief.

Dietary Changes That Reduce GLP-1-Related Reflux

Dietary modification is critical for managing acid reflux on GLP-1 medications because the core problem — a full stomach for extended periods — is directly influenced by what and how much you eat. The goal is to minimize both the volume of gastric contents and the production of acid during the extended emptying window.

Sleep Position: Why It Matters More on GLP-1s

Nighttime acid reflux is particularly problematic on GLP-1 medications because the evening meal may still be sitting in the stomach at bedtime. When you lie flat, gravity no longer helps keep stomach contents below the LES. The evidence-based solution is left-side sleeping with head elevation. Multiple studies have demonstrated that lying on the left side significantly reduces esophageal acid exposure compared to lying on the right side or flat on the back. The anatomy explains why: the stomach is positioned with the gastric fundus (the upper dome) on the left and the gastroesophageal junction slightly to the right. When you lie on your left side, the fundus drops below the junction, and gastric contents pool away from the esophageal opening.

Elevating the head of the bed by 6-8 inches — using a wedge pillow or placing blocks under the bed legs — adds gravitational assistance. A 2006 study in Archives of Internal Medicine found that head-of-bed elevation reduced esophageal acid exposure by 67% compared to sleeping flat. For GLP-1 patients, combining left-side positioning with head elevation is the most effective non-pharmacological nighttime reflux intervention. Note that simply using extra pillows does not work as well as a true wedge or bed elevation, because pillows bend the body at the waist, which can actually increase abdominal pressure.

Lifestyle Modifications Beyond Diet

When to See a Doctor About GLP-1 Reflux

While most GLP-1-related acid reflux is manageable with the strategies above, certain symptoms require prompt medical evaluation. Difficulty swallowing (dysphagia) may indicate esophageal inflammation or stricture from chronic acid exposure. Unintentional weight loss beyond what is expected from the medication, persistent vomiting, chest pain (which should always be evaluated to rule out cardiac causes), blood in vomit or black tarry stools, and hoarseness or chronic cough that does not respond to reflux treatment all warrant a visit to your healthcare provider. Patients with pre-existing Barrett's esophagus or a history of severe GERD should discuss acid monitoring with their gastroenterologist before or shortly after starting GLP-1 therapy.